APA Zitierstil

Cao, Y., Xiao, G., Qiu, X., Ye, S., & Lin, T. (2014). Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients. PLoS One.

Chicago Zitierstil

Cao, Yabing, Guangli Xiao, Xibin Qiu, Sheng Ye, und Tongyu Lin. "Efficacy and Safety of Crizotinib Among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients." PLoS One 2014.

MLA Zitierstil

Cao, Yabing, et al. "Efficacy and Safety of Crizotinib Among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients." PLoS One 2014.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.